Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis

REFERENCES

• Asano Y. Future treatments in systemic sclerosis. J Dermatol. 2010;37:54–70.
   PubMed Web of Science ®Google Scholar
• Distler JH, Gay S, Distler 0. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology (Oxford). 2006;45 Suppl 3:iii26–7.
   Google Scholar
• Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med. 2010;14: 1241–54.
   Google Scholar
• Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vas-cular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10:165–77.
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol. 2010;25:387–96.
   PubMed Web of Science ®Google Scholar
• Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA. 2002;99: 11205–10.
   Google Scholar
• Rykala J, Przybylowska K, Majsterek I, Pasz-Walczak G, Sygut A, Dziki A, et al. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res. 2011;17:809–17.
   Google Scholar
• Pousa ID, Mate J, Salcedo-Mora X, Abreu MT, Moreno-Otero R, Gisbert JP. Role of vascular endothelial growth factor and an-giopoietin systems in serum of Crohn's disease patients. Inflamm Bowel Dis. 2008;14:61–7.
   Google Scholar
• Duerias Pousa I, Mate Jimenez J, Salcedo Mora X, Abreu MT, Moreno-Otero R, Gisbert JP. Analysis of soluble angiogenic factors in Crohn's disease: a preliminary study. Gastroenterol Hepatol. 2007;30:518–24.
   Google Scholar
• Yoshizaki A, Nakayama T, Naito S, Sekine I. Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the pro-gression of ulcerative colitis. Dig Dis Sci. 2009;54:2094–9.
   PubMedGoogle Scholar
• Kiimpers P, David S, Haubitz M, Hellpap J, Horn R, Brocker V. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis. 2009;68:1638–43.
   PubMedGoogle Scholar
• Michalska-Jakubus M, Kowal-Bielecka 0, Chodorowska G, Bielecki M, Krasowska D. Angiopoietins-1 and -2 are differen-tially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease. Rheumatology (Oxford). 2011; 50:746–55.
   Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classifi-cation, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.
   Google Scholar
• Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, et al. Serum levels of KL-6 as a useful marker for evaluating pul-monary fibrosis in patients with systemic sclerosis. J Rheumatol. 2000;27:930–4.
   PubMed Web of Science ®Google Scholar
• Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, et al. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with sys-temic sclerosis. Arthritis Rheum. 2001;44:1363–9.
   PubMed Web of Science ®Google Scholar
• Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at 10-mm incre-ments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. MR Am J Roentgenol. 1997;169:977–83.
   PubMed Web of Science ®Google Scholar
• Mihai C, Tervaert JW. Anti-endothelial cell antibodies in sys-temic sclerosis. Ann Rheum Dis. 2010;69:319–24.
   PubMed Web of Science ®Google Scholar
• Bordron A, Dueymes M, Levy Y, Jamin C, Leroy P, Piette JC, et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest. 1998;101: 2029–35.
   PubMed Web of Science ®Google Scholar
• Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum. 2000;43:2550–62.
   PubMed Web of Science ®Google Scholar
• Wusirika R, Ferri C, Main M, Knight DA, Waldman WJ, Ross P Jr, et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol. 2003;120: 596–606.
   Google Scholar
• Laplante P, Raymond MA, Gagnon G, Vigneault N, Sasseville AM, Langelier Y, et al. Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the patho-physiology of systemic sclerosis. J Immunol. 2005;174:5740–9.
   PubMed Web of Science ®Google Scholar
• Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996;98:785–92.
   PubMed Web of Science ®Google Scholar
• Parra ER, Aguiar AC, Teodoro WR, de Souza R, Yoshinari NH, Capelozzi VL. Collagen V and vascular injury promote lung architectural changes in systemic sclerosis. Clin Respir J. 2009; 3:135–42.
   Google Scholar
• Casale R, Generini S, Luppi F, Pignone A, Matucci-Cerinic M. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dys-function (Raynaud's phenomenon) in a case of early systemic sclerosis. Arthritis Rheum. 2004;51:665–9.
   Google Scholar
• Apras S, Ertenli I, Ozbalkan Z, Kiraz S, Ozturk MA, Hazned-aroglu IC, et al. Effects of oral cyclophosphamide and prednis-olone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum. 2003;48:2256–61.
   Google Scholar
• Furuya Y, Okazaki Y, Kaji K, Sato S, Takehara K, Kuwana M. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis. Rheuma-tology (Oxford). 2010;49:2375–80.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Pittet JF. Angiopoietin-2: modulator of vascular permeability in acute lung injury? PLoS Med. 2006;3:e113.
   Google Scholar
• Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3:e46.
   PubMed Web of Science ®Google Scholar